Relevance of Biomarkers Currently in Use or Research for Practical Diagnosis Approach of Neonatal Early-Onset Sepsis
Neonatal early-onset sepsis (EOS) is defined as an invasive infection that occurs in the first 72 h of life. The incidence of EOS varies from 0.5–2% live births in developed countries, up to 9.8% live births in low resource settings, generating a high mortality rate, especially in extremely low birt...
Main Authors: | Maura-Adelina Hincu, Gabriela-Ildiko Zonda, Gabriela Dumitrita Stanciu, Dragos Nemescu, Luminita Paduraru |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/7/12/309 |
Similar Items
-
Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis
by: Mehmet Saldir, et al.
Published: (2015-12-01) -
Nasopharyngeal colonization at birth and the development of early-onset neonatal sepsis
by: Andi Dwi Bahagia Febriani, et al.
Published: (2020-10-01) -
A new approach to managing neonates born to mothers at risk for early-onset neonatal sepsis: is it cost-effective and can it reduce NICU admissions?
by: Nagwa Sabry, et al.
Published: (2021-01-01) -
Statistical validity of interleukin-6 as a biomarker for the diagnosis of early-onset neonatal sepsis
by: Sriparna Basu, et al.
Published: (2012-03-01) -
Late-onset neonatal sepsis: Overview of risk factors and bacterial etiology in a tertiary care hospital in North India
by: Sunit Pathak, et al.
Published: (2018-01-01)